IGF-1 receptor haploinsufficiency leads to age-dependent development of metabolic syndrome

Biochem Biophys Res Commun. 2017 May 13;486(4):937-944. doi: 10.1016/j.bbrc.2017.03.129. Epub 2017 Mar 25.

Abstract

Individuals born small for gestational age (SGA) are at a higher risk of developing the metabolic syndrome later in life. IGF-1 resistance has been reported in placentae from SGA births and mutations in the Igf1 receptor gene have been reported in several cohorts of SGA subjects. We have used the Igf1r heterozygous (Igf1r+/-) male mouse as a model to investigate the mechanisms by which Igf1r haploinsufficiency leads to insulin resistance. Despite exhibiting IGF-1 resistance, insulin signaling is enhanced in young Igf1r+/- mice but is attenuated in the muscle of old Igf1r+/- mice. Although smaller than WT (wild type) mice, old-aged Igf1r+/- had increased adiposity and exhibit increased lipogenesis. We hypothesize that IGF-1 resistance initially causes a transient increase in insulin signaling thereby promoting a lipogenic phenotype, which subsequently leads to insulin resistance.

Keywords: Haploinsufficiency; IGF-1; IGF-1R; Igf1r(+/-); Insulin; Lipogenesis; Metabolic syndrome; SGA; Type 2 diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / genetics*
  • Animals
  • Female
  • Genetic Predisposition to Disease / genetics
  • Haploinsufficiency / genetics*
  • Humans
  • Infant, Newborn
  • Infant, Small for Gestational Age*
  • Insulin Resistance / genetics*
  • Male
  • Metabolic Syndrome / genetics*
  • Mice
  • Mice, Inbred C57BL
  • Receptor, IGF Type 1 / genetics*

Substances

  • Receptor, IGF Type 1